Zantac cancer concerns halt shipments of generic versions of popular heartburn medication
https://healthell.blogspot.com/2019/09/zantac-cancer-concerns-halt-shipments.html
Zantac cancer concerns halt shipments of generic versions of popular heartburn medication
A division of Novartis, a pharmaceutical company based in Switzerland, has halted shipments of generic versions of the heartburn medication Zantac after the Food and Drug Administration (FDA) recently announced it found trace amounts of a potentially cancer-causing chemical in the product.
